Investigating the link between the atheronals and aging
研究动脉粥样硬化与衰老之间的联系
基本信息
- 批准号:7273894
- 负责人:
- 金额:$ 18.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingAldehydesAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAnatomic SitesAnimalsApolipoprotein EArterial Fatty StreakArteriesAtherosclerosisBiologicalBlood VesselsCellsChemicalsChronicDiseaseDistantElderlyExposure toHalf-LifeHumanIn VitroInflammationInflammatoryLifeLinkLiquid substanceLocationLow Density Lipoprotein ReceptorLow-Density LipoproteinsMediator of activation proteinModelingMouse StrainsMusOrganPeptidesPhysiologicalPlasmaResearchResearch PersonnelSeveritiesSystemTissuesTransgenic OrganismsVascular Endotheliumage effectage relatedbody systembrain tissuein vivoleukocyte activationmouse modelneurotoxicpeptide Aprogramsresponse
项目摘要
DESCRIPTION (provided by applicant): This proposal, submitted in response to RFA-AG-05-011, explores the age-related changes of the newly discovered inflammation-derived lipidic aldehydes, atheronal-A and -B. We have recently shown that the atheronals are present in vivo within human atherosclerotic plaque material, plasma and brain tissue. Critically, we have shown that the levels of the atheronals within inflamed arteries are significantly elevated upon leukocyte activation. Furthermore we have shown in vitro that the atheronals have biological effects that make them inflammatory mediators. Furthermore we have shown that the atheronals accelerate the misfolding and aggregation of the neurotoxic beta-amyloid (A?) peptide. Atheronals have a plasma half-life in mice of several minutes, are freely diffusible between cells and fluid compartments and can thus can impact distant anatomic sites away from the active location of inflammation. Thus, as byproducts of the chronic inflammation that characterizes atherosclerosis within the vascular endothelium, the atheronals may serve as antagonistic chemical mediators of late life disease, both atherosclerosis progression and Alzheimer's disease (AD). We hypothesize therefore that the atheronals, as inflammatory mediators, may be a chemical link that explains the known epidemiologic convergence between atherosclerosis and AD, two major diseases of aging, and may also serve as an example of how ageing within one organ system can affect another. This R21 proposal outlines research in animal systems to quantify the effect of ageing on atheronal levels, and whether atheronal exposure in early life can impact later life pathophysiological changes. This proposal will investigate the relationships of age-related changes in atheronal levels to physiologic and pathophysiologic ageing changes in organ function by investigating the following three specific aims:
1) Specific aim #1 Determine the effect of age and atherosclerosis progression on plasma and vascular tissue levels of the atheronals in two murine models of atherosclerosis, the Apo-E deficient (ApoE-/-) and LDLreceptor deficient (LDL-/-) mouse strains. 2) Specific aim #2 Determine the effect of age and atherosclerosis progression on brain tissue levels of the atheronals in the , ApoE-/- and LDL-/- murine models of atherosclerosis. 3) Specific aim # 3 Determine if early age exposure to atheronals results in an increased severity of the late life ageing disorders of atherosclerosis and Alzheimer's disease in murine models of atherosclerosis, ApoE-/- and LDL-/- and a human APP transgenic mouse model (Jackson labs).
描述(由申请人提供):本提案是为响应RFA-AG-05-011而提交的,旨在探索新发现的炎症源性雌二醇(atheronal-A和B)的年龄相关变化。我们最近发现动脉粥样硬化存在于人体动脉粥样硬化斑块物质、血浆和脑组织中。重要的是,我们已经表明,炎症动脉内的动脉粥样硬化水平在白细胞活化后显著升高。此外,我们已经在体外证明动脉粥样硬化具有生物学效应,使其成为炎症介质。此外,我们已经表明,动脉粥样硬化加速错误折叠和聚集的神经毒性β-淀粉样蛋白(A?)肽。动脉粥样硬化剂在小鼠中的血浆半衰期为几分钟,可在细胞和流体隔室之间自由扩散,因此可影响远离炎症活动部位的远距离解剖部位。因此,作为血管内皮内动脉粥样硬化特征的慢性炎症的副产品,动脉粥样硬化物质可能充当晚年疾病(动脉粥样硬化进展和阿尔茨海默病(AD))的拮抗性化学介质。因此,我们假设动脉粥样硬化,作为炎症介质,可能是一种化学联系,解释了动脉粥样硬化和AD,两种主要的衰老疾病之间的流行病学收敛,也可以作为一个例子,一个器官系统内的衰老如何影响另一个。该R21提案概述了动物系统中的研究,以量化衰老对动脉粥样硬化水平的影响,以及早期生命中的动脉粥样硬化暴露是否会影响晚年的病理生理变化。本提案将通过调查以下三个具体目标,调查动脉粥样硬化水平的年龄相关变化与器官功能的生理和病理生理老化变化之间的关系:
1)具体目标#1确定年龄和动脉粥样硬化进展对两种动脉粥样硬化小鼠模型(Apo-E缺陷(ApoE-/-)和LDL受体缺陷(LDL-/-)小鼠品系)中动脉粥样硬化的血浆和血管组织水平的影响。2)具体目标#2确定年龄和动脉粥样硬化进展对ApoE-/-和LDL-/-动脉粥样硬化小鼠模型中动脉粥样硬化脑组织水平的影响。3)具体目标#3在动脉粥样硬化的鼠模型、ApoE-/-和LDL-/-以及人APP转基因小鼠模型(杰克逊实验室)中确定早期暴露于动脉粥样硬化是否导致动脉粥样硬化和阿尔茨海默病的晚年衰老障碍的严重程度增加。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cholesterol secosterol adduction inhibits the misfolding of a mutant prion protein fragment that induces neurodegeneration.
胆固醇仲甾醇加合可抑制引起神经变性的突变朊病毒蛋白片段的错误折叠。
- DOI:10.1002/anie.200904524
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Scheinost,JohannaC;Witter,DanielP;Boldt,GrantE;Offer,John;WentworthJr,Paul
- 通讯作者:WentworthJr,Paul
The ratio of cholesterol 5,6-secosterols formed from ozone and singlet oxygen offers insight into the oxidation of cholesterol in vivo.
由臭氧和单线态氧形成的胆固醇 5,6-仲甾醇的比例可以深入了解体内胆固醇的氧化。
- DOI:10.1039/b821584g
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Wentworth,AnitaD;Song,Byeong-Doo;Nieva,Jorge;Shafton,Asher;Tripurenani,Sangeetha;WentworthJr,Paul
- 通讯作者:WentworthJr,Paul
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL WENTWORTH其他文献
PAUL WENTWORTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL WENTWORTH', 18)}}的其他基金
C3 Tumor Associated Carbohydrate Antigen Bioconjugates
C3 肿瘤相关碳水化合物抗原生物缀合物
- 批准号:
8424948 - 财政年份:2012
- 资助金额:
$ 18.5万 - 项目类别:
C3 Tumor Associated Carbohydrate Antigen Bioconjugates
C3 肿瘤相关碳水化合物抗原生物缀合物
- 批准号:
8301502 - 财政年份:2012
- 资助金额:
$ 18.5万 - 项目类别:
C3 chemical conjugation to improve the anti-cocaine immune response
C3化学缀合改善抗可卡因免疫反应
- 批准号:
8233313 - 财政年份:2011
- 资助金额:
$ 18.5万 - 项目类别:
C3 chemical conjugation to improve the anti-cocaine immune response
C3化学缀合改善抗可卡因免疫反应
- 批准号:
8092919 - 财政年份:2011
- 资助金额:
$ 18.5万 - 项目类别:
Lactobacilli surface antibody expression for in vivo protection against cholera
乳酸杆菌表面抗体表达可体内预防霍乱
- 批准号:
7772625 - 财政年份:2010
- 资助金额:
$ 18.5万 - 项目类别:
Lactobacilli surface antibody expression for in vivo protection against cholera
乳酸杆菌表面抗体表达可体内预防霍乱
- 批准号:
8033092 - 财政年份:2010
- 资助金额:
$ 18.5万 - 项目类别:
Beauveriolide-Derived Cyclodepsipeptides as a New Class of Anti-Alzheimer's Drugs
Beauveriolide 衍生的环缩酚肽作为一类新型抗阿尔茨海默病药物
- 批准号:
7758245 - 财政年份:2009
- 资助金额:
$ 18.5万 - 项目类别:
Antibody Generation of ROS and Macular Degeneration
ROS 和黄斑变性的抗体生成
- 批准号:
7273892 - 财政年份:2006
- 资助金额:
$ 18.5万 - 项目类别:
Investigating the link between the atheronals and aging
研究动脉粥样硬化与衰老之间的联系
- 批准号:
7124089 - 财政年份:2006
- 资助金额:
$ 18.5万 - 项目类别:
Antibody Generation of ROS and Macular Degeneration
ROS 和黄斑变性的抗体生成
- 批准号:
7096710 - 财政年份:2006
- 资助金额:
$ 18.5万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 18.5万 - 项目类别:
Operating Grants